Pharmaceutical Regulatory Environment Challenges and Opportunities in the Gulf Region /
The Middle East represents the next growth market for the global biopharmaceutical industry but to date there has been limited information about the regulatory review processes employed in these countries. A thorough examination of the strategies currently being implemented by the Gulf States is con...
Κύριοι συγγραφείς: | , , , |
---|---|
Συγγραφή απο Οργανισμό/Αρχή: | |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Adis,
2015.
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- 1. Overview of Medicines Regulatory Systems in the Gulf Region
- 2. The Regulatory Review Process in the Gulf Region
- 3. Regulatory Review Times in the Gulf Region
- 4. Quality Measures in the Gulf Regulatory Practices
- 5. The Current Status of the Common Technical Document
- 6. The Current Status of Drug Safety and Pharmacovigilance
- 7. The Centralized Regulatory Review in the Gulf Region
- 8. The Gulf States Assessment and Experience With the Centralised Procedure
- 9. The Pharmaceutical Companies Assessment and Experience With the Centralised Procedure
- 10. Proposal For an Improved Centralized Regulatory System
- 11. The Strategic Planning Process of the GCC Regulatory Authorities: Barriers And Solutions
- 12. The Regulatory Dilemma in the Gulf Region: The Way Forward.